![Olivier Saidi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Olivier Saidi
Nessuna posizione attualmente
Profilo
Olivier Saidi is Chief Technology Officer of Aureon Laboratories, Inc.
Precedenti posizioni note di Olivier Saidi
Società | Posizione | Fine |
---|---|---|
Aureon Biosciences, Inc.
![]() Aureon Biosciences, Inc. BiotechnologyHealth Technology Aureon Biosciences, Inc. designs and develops prognostic tests. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence, disease progression and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. The company was founded by Robert H. Singer, Charles M. Cohen, Jonathan Edelson, Olivier Saidi and Carlos Cordón-Cardó in 2001 and is headquartered in Yonkers, NY. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Aureon Biosciences, Inc.
![]() Aureon Biosciences, Inc. BiotechnologyHealth Technology Aureon Biosciences, Inc. designs and develops prognostic tests. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence, disease progression and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. The company was founded by Robert H. Singer, Charles M. Cohen, Jonathan Edelson, Olivier Saidi and Carlos Cordón-Cardó in 2001 and is headquartered in Yonkers, NY. | Health Technology |
- Borsa valori
- Insiders
- Olivier Saidi